Semnur Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Stock Symbol
  • SMNR

Stock Symbol

  • Investments
  • 1

Semnur Pharmaceuticals General Information

Description

Developer of non-opioid pain therapies designed for the treatment of chronic radicular pain and sciatica. The company's lead product is a novel injectable corticosteroid gel formulation administered epidurally without preservatives or particulates, enabling healthcare providers to offer sciatica patients targeted pain relief and improved disability scores through a specialized non-opioid treatment option.

Contact Information

Formerly Known As
Denali Capital Acquisition
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 960 San Antonio Road
  • Palo Alto, CA 94303
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 960 San Antonio Road
  • Palo Alto, CA 94303
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Semnur Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Semnur Pharmaceuticals‘s full profile, request access.

Request a free trial

Semnur Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Semnur Pharmaceuticals‘s full profile, request access.

Request a free trial

Semnur Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-opioid pain therapies designed for the treatment of chronic radicular pain and sciatica. The company's
Drug Discovery
Palo Alto, CA

Tampa, FL
 

Hilliard, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Semnur Pharmaceuticals Competitors (30)

One of Semnur Pharmaceuticals’s 30 competitors is Pacira BioSciences, a Formerly VC-backed company based in Tampa, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pacira BioSciences Formerly VC-backed Tampa, FL
Sollis Therapeutics Venture Capital-Backed Hilliard, OH
Phoenix PharmaLabs Venture Capital-Backed Salt Lake City, UT
Bridge Therapeutics Venture Capital-Backed Birmingham, AL
Pfizer (Vienna) Corporation Vienna, Austria
You’re viewing 5 of 30 competitors. Get the full list »

Semnur Pharmaceuticals Patents

Semnur Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2974657-A1 Injectable pharmaceutical composition comprising dexamethasone sodium phosphate Active 21-Jan-2015
CA-2974657-C Injectable pharmaceutical composition comprising dexamethasone sodium phosphate Active 21-Jan-2015
EP-3247329-B1 Injectable pharmaceutical composition comprising dexamethasone sodium phosphate Active 21-Jan-2015
EP-3247329-B3 Injectable pharmaceutical composition comprising dexamethasone sodium phosphate Active 21-Jan-2015
EP-3925597-A1 Injectable pharmaceutical composition comprising dexamethasone sodium phosphate Active 21-Jan-2015 A61K47/36
To view Semnur Pharmaceuticals’s complete patent history, request access »

Semnur Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Semnur Pharmaceuticals‘s full profile, request access.

Request a free trial

Semnur Pharmaceuticals Acquisitions (1)

Semnur Pharmaceuticals’s most recent deal was a Merger/Acquisition with Denali Capital Acquisition. The deal was made on 22-Sep-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Denali Capital Acquisition 22-Sep-2025 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Semnur Pharmaceuticals’s complete acquisitions history, request access »

Semnur Pharmaceuticals FAQs

  • When was Semnur Pharmaceuticals founded?

    Semnur Pharmaceuticals was founded in 2013.

  • Where is Semnur Pharmaceuticals headquartered?

    Semnur Pharmaceuticals is headquartered in Palo Alto, CA.

  • What industry is Semnur Pharmaceuticals in?

    Semnur Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Semnur Pharmaceuticals a private or public company?

    Semnur Pharmaceuticals is a Public company.

  • What is Semnur Pharmaceuticals’s stock symbol?

    The ticker symbol for Semnur Pharmaceuticals is SMNR.

  • Who are Semnur Pharmaceuticals’s competitors?

    Pacira BioSciences, Sollis Therapeutics, Phoenix PharmaLabs, Bridge Therapeutics, and Pfizer (Vienna) are some of the 30 competitors of Semnur Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process